AtriCure, Inc. (ATRC)
52.59
+3.67
(+7.50%)
USD |
NASDAQ |
Sep 02, 16:00
52.62
+0.03
(+0.06%)
After-Hours: 20:00
AtriCure Research and Development Expense (Annual) : 90.17M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 90.17M |
| December 31, 2024 | 81.16M |
| December 31, 2023 | 73.92M |
| December 31, 2022 | 57.34M |
| December 31, 2021 | 48.51M |
| December 31, 2020 | 43.07M |
| December 31, 2019 | 41.23M |
| December 31, 2018 | 34.72M |
| December 31, 2017 | 34.14M |
| December 31, 2016 | 35.82M |
| December 31, 2015 | 25.74M |
| December 31, 2014 | 18.60M |
| December 31, 2013 | 13.44M |
| Date | Value |
|---|---|
| December 31, 2012 | 12.15M |
| December 31, 2011 | 11.86M |
| December 31, 2010 | 11.53M |
| December 31, 2009 | 11.41M |
| December 31, 2008 | 10.61M |
| December 31, 2007 | 10.99M |
| December 31, 2006 | 12.22M |
| December 31, 2005 | 9.109M |
| December 31, 2004 | 4.422M |
| December 31, 2003 | 2.501M |
| December 31, 2002 | 2.721M |
| December 31, 2001 | 1.838M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Boston Scientific Corp. | 2.052B |
| Abbott Laboratories | 2.889B |
| AngioDynamics, Inc. | 29.45M |
| Alphatec Holdings, Inc. | 76.27M |
| Baxter International, Inc. | 503.00M |